<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04515693</url>
  </required_header>
  <id_info>
    <org_study_id>19-010067</org_study_id>
    <nct_id>NCT04515693</nct_id>
  </id_info>
  <brief_title>Exploring Psychometric Properties of a New Version of the 6MWT in the Acute Stroke Population</brief_title>
  <official_title>Exploring Psychometric Properties of a New Version of the 6MWT in the Acute Stroke Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess inter- and intra-rater reliability of the 6MWT in&#xD;
      people with acute stroke who require various levels of assistance with walking.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 25, 2020</start_date>
  <completion_date type="Anticipated">March 25, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6 Minute walk test</measure>
    <time_frame>8 minutes (2 minutes for set-up, 6 minutes to execute)</time_frame>
    <description>walking endurance assessment measured in meters of total distance completed over 6 minutes</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acute Stroke</condition>
  <arm_group>
    <arm_group_label>Maximal Assist group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with acute stroke who ambulate with Maximal assistance of 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Assist group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with acute stroke who ambulate with Moderate assistance of 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minimal Assist group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with acute stroke who ambulate with Minimal assistance of 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supervision/Modified Independence/Independence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who walk without physical assistance of a helper.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>6 Minutes Walking Test</intervention_name>
    <description>A walkway of 12 meters will be marked with one cone at each end. The patient will be instructed to walk back and forth as many times as possible in six minutes.</description>
    <arm_group_label>Maximal Assist group</arm_group_label>
    <arm_group_label>Minimal Assist group</arm_group_label>
    <arm_group_label>Moderate Assist group</arm_group_label>
    <arm_group_label>Supervision/Modified Independence/Independence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years old&#xD;
&#xD;
          -  Primary diagnosis of an acute or hemorrhagic stroke&#xD;
&#xD;
          -  Admitted into the acute or acute rehab setting and is appropriate for physical therapy&#xD;
             services.&#xD;
&#xD;
          -  Can ambulate with 1 person assistance and a device as needed, with no more than&#xD;
             maximal assistance required. The patient must be able to independently advance the&#xD;
             lower extremity forward, but can receive maximal assistance for blocking, bracing or&#xD;
             postural control during ambulation.&#xD;
&#xD;
          -  Can stand and/or ambulate for at least 6 minutes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemodynamically unstable&#xD;
&#xD;
          -  Unstable medical co-morbidities such as: active bleeding, recurring seizures,&#xD;
             uncontrolled hypertension (permissive HTN orders ok)&#xD;
&#xD;
          -  Patients with bilateral acute stroke&#xD;
&#xD;
          -  Patients who are unable to follow 1 step commands as determined by the screening&#xD;
             physiatrist&#xD;
&#xD;
          -  Orthopedic co-morbidities that place a weight-bearing restriction on the lower&#xD;
             extremities such as acute fracture, joint replacement, or other musculoskeletal injury&#xD;
&#xD;
          -  Any other condition that would limit a patient's ability to remain in a standing&#xD;
             position with assistance for 6 minutes at a time.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannah Karstetter, PT, DPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 14, 2020</study_first_submitted>
  <study_first_submitted_qc>August 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2020</study_first_posted>
  <last_update_submitted>August 8, 2021</last_update_submitted>
  <last_update_submitted_qc>August 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Hannah M. Karstetter</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

